Home › Blood Cancers › Illinois › Chicago
Blood Cancers clinical trials in Chicago, IL
16 studies for Blood Cancers are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
RecruitingPhase 3
- The University of Chicago ( Site 0020), Chicago
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
RecruitingPhase 3
- Northwestern University, Chicago
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- Northwestern, Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- and 1 more
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RecruitingObservational study
- Swedish Covenant Hospital, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
Recruiting
- Northwestern University Feinberg School of Medicine, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Recruiting
- University of Chicago Comprehensive Cancer Center, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RecruitingPhase 1/2
- Northwestern Memorial Hospital, Chicago
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer
RecruitingObservational studyHealthy volunteers welcome
- Tempus AI, Chicago
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- and 2 more
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RecruitingPhase 1
- University of Chicago, Chicago
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
RecruitingPhase 1
- Northwestern University - Feinberg School of Medicine, Chicago
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
RecruitingObservational study
- MPN Research Foundation, Chicago
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Blood Cancers trials in other cities
- Houston, TX46 studies
- Boston, MA28 studies
- New York City, NY26 studies
- Washington, DC19 studies
- Seattle, WA18 studies
- Baltimore, MD18 studies
- Los Angeles, CA18 studies
- Durham, NC16 studies
- Edison, NJ14 studies
- Columbus, OH14 studies
- Philadelphia, PA14 studies
- Nashville, TN13 studies
Other studies in Chicago
- Breast Cancer59 studies
- Non-Small Cell Lung Cancer59 studies
- Cancer (all types)51 studies
- Prostate Cancer45 studies
- Lung Cancer43 studies
- Metastatic Cancer42 studies
- Obesity40 studies
- Ovarian Cancer36 studies
- Colorectal Cancer32 studies
- Stroke31 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.